← All Sponsors
SPONSOR

Brexogen Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Atopic Dermatitis
NCT06055361 Phase 1
Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
United States View Trial →